Sorry, you need to enable JavaScript to visit this website.
Skip to main content

This site is intended for US Population-Health Decision Makers or similar entities at hospitals and US oncology practices.

Resources for Implementing Quality Initiatives in MF

Julianne Orr Darling, PharmD, video on Quality Initiatives in Myelofibrosis

Risk Assessment and Quality Initiatives in Myelofibrosis (MF)

Watch Julianne Orr Darling, PharmD, BCOP, an Oncology and Clinical Pharmacist at Indiana University Health, discuss the importance of taking a proactive approach to risk stratification when managing patients with MF. Review risk stratification criteria and how pharmacists can create a list of patients for a potential Quality Initiative. Watch this video and download a brochure about MF risk below as a PDF.

Download a PDF of a brochure

Learn How to Implement a Quality Initiative for Patients With Myelofibrosis (MF)

This guide for pharmacy directors and clinical pharmacists can help you proactively identify and support patients with symptoms associated with MF who might be in need of better management.

Download PDF
Download a PDF of a brochure

Identifying Risk and Setting Up Quality Initiatives for Patients With Myelofibrosis (MF)

Get information that may help you identify and evaluate risk profiles among your patients with MF. You will also find risk stratification guidelines and insights into strategies for assessing and monitoring risk.

Download PDF